Your pre-operative instructions will tell you exactly which supplements to pause and when
CrossRef Anti-diabetic Drugs and Cancer: Integrated Mechanisms of Tumor Suppression and Clinical Translation Mahya Asadalizadeh, Mohammad Kazem Molavi Rahbar, Tabassom Mahmoudie, Mahshid Abbasi, Mitra Akbari, Davoud Shakiba, Aida Mohammadiun Shabestari, Meysam Ebrahimifar Indian Journal of Clinical Biochemistry.2026;[Epub] CrossRef Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis Gaetano Lauri, Paolo Giorgio Arcidiacono, Antonio Facciorusso, Gabriele Capurso, Matteo Tacelli Pancreatology.2026;[Epub] CrossRef GLP-1 Receptor Agonists: Therapeutic Potential and Emerging Concerns Klaudia Nowak, Krzysztof upina, Aleksandra Kalisz, ucja Ilkiewicz, Jakub Janczura Current Pharmacology Reports.2026;[Epub] CrossRef Optimizing glycemic control in oncology patients with diabetes mellitus S
Since researchers used data from Medicare administrative claims, it is possible that they missed some health information or that there was misclassification, such as misclassification of depression cases
however, if only key grading nodes were missing, the study was not excluded but was strictly downgraded during the evidence grading process
To further investigate tumor angiogenesis markers for breast cancer for evaluation of anti-angiogenic therapy efficacy, promoting vascular normalization may be a necessary prerequisite for reversing drug resistance
